Синдром Гийена-Барре

Hadden RD, Hughes RA. Management of inflammatory neuropathies. J Neurol Neurosurg Psychiatry. 2003 Jun;74 Suppl 2:ii9-14.Полный текст  Аннотация

Hahn AF. Guillain-Barré syndrome. Lancet. 1998 Aug 22;352(9128):635-41. Аннотация

Stowe J, Andrews N, Wise L, et al. Investigation of the temporal association of Guillain-Barré syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. Am J Epidemiol. 2009 Feb 1;169(3):382-8.Полный текст  Аннотация

Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2014 Sep 19;(9):CD002063.Полный текст  Аннотация

Lawn ND, Fletcher DD, Henderson RD, et al. Anticipating mechanical ventilation in Guillain-Barré syndrome. Arch Neurol. 2001;58:893-898.Полный текст  Аннотация

Hughes RA, Brassington R, Gunn AA, et al. Corticosteroids for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2016 Oct 24;(10):CD001446.Полный текст  Аннотация

1. Hadden RD, Hughes RA. Management of inflammatory neuropathies. J Neurol Neurosurg Psychiatry. 2003 Jun;74 Suppl 2:ii9-14.Полный текст  Аннотация

2. Hiraga A, Mori M, Ogawara K, et al. Recovery patterns and long term prognosis for axonal Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2005 May;76(5):719-22.Полный текст  Аннотация

3. Guillain G, Barré JA, Strohl A. Radiculoneuritis syndrome with hyperalbuminosis of cerebrospinal fluid without cellular reaction. Notes on clinical features and graphs of tendon reflexes. 1916 [in French]. Ann Med Interne (Paris). 1999 Jan;150(1):24-32. Аннотация

4. Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore). 1969 May;48(3):173-215. Аннотация

5. Bickerstaff ER. Brain-stem encephalitis; further observations on a grave syndrome with benign prognosis. Br Med J. 1957 Jun 15;1(5032):1384-7.Полный текст  Аннотация

6. Ropper AH. Unusual clinical variants and signs in Guillain-Barré syndrome. Arch Neurol. 1986 Nov;43(11):1150-2. Аннотация

7. Mericle RA, Triggs WJ. Treatment of acute pandysautonomia with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry. 1997 May;62(5):529-31.Полный текст  Аннотация

8. Anzai T, Uematsu D, Takahashi K, et al. Guillain-Barré syndrome with bilateral tonic pupils. Intern Med. 1994 Apr;33(4):248-51.Полный текст  Аннотация

9. Ropper AH. Further regional variants of acute immune polyneuropathy. Bifacial weakness or sixth nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngeal-cervical-brachial weakness. Arch Neurol. 1994 Jul;51(7):671-5. Аннотация

10. Ropper AH. The Guillain-Barré syndrome. N Engl J Med. 1992 Apr 23;326(17):1130-6. Аннотация

11. Winer JB, Hughes RA, Anderson MJ, et al. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry. 1988 May;51(5):613-8.Полный текст  Аннотация

12. Poropatich KO, Walker CL, Black RE. Quantifying the association between Campylobacter infection and Guillain-Barré syndrome: a systematic review. J Health Popul Nutr. 2010 Dec;28(6):545-52.Полный текст  Аннотация

13. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome. Appropriate number of plasma exchanges in Guillain-Barré syndrome. Ann Neurol. 1997 Mar;41(3):298-306. Аннотация

14. Ropper A, Wijdicks E, Truax B. Guillain-Barré syndrome. Philadelphia, PA: F.A. Davies; 1991.

15. Hahn AF. Guillain-Barré syndrome. Lancet. 1998 Aug 22;352(9128):635-41. Аннотация

16. Ropper AH, Wijdicks E, Truax B. Guillain-Barré syndrome. Philadelphia, PA: F.A. Davies; 1991:22-30.

17. Jones HR Jr. Guillain-Barré syndrome in children. Curr Opin Pediatr. 1995 Dec;7(6):663-8. Аннотация

18. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain. 1995 Jun;118 ( Pt 3):597-605. Аннотация

19. Jacobs BC, van Doorn PA, Schmitz PI, et al. Campylobacter jejuni infections and anti-GM1 antibodies in GBS. Ann Neurol. 1996 Aug;40(2):181-7. Аннотация

20. Fisher M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med. 1956 Jul 12;255(2):57-65. Аннотация

21. Lyu RK, Tang LM, Cheng SY, et al. Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients. J Neurol Neurosurg Psychiatry. 1997 Oct;63(4):494-500.Полный текст  Аннотация

22. Geleijns K, Emonts M, Laman JD, et al. Genetic polymorphisms of macrophage-mediators in Guillain-Barré syndrome. J Neuroimmunol. 2007 Oct;190(1-2):127-30. Аннотация

23. Schwerer B. Antibodies against gangliosides: a link between preceding infection and immunopathogenesis of Guillain-Barré syndrome. Microbes Infect. 2002 Mar;4(3):373-84. Аннотация

24. Hadden RD, Karch H, Hartung HP, et al; Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Preceding infections, immune factors, and outcome in Guillain-Barré syndrome. Neurology. 2001 Mar 27;56(6):758-65. Аннотация

25. Van Koningsveld R, Van Doorn PA, Schmitz PI, et al. Mild forms of Guillain-Barré syndrome in an epidemiologic survey in The Netherlands. Neurology. 2000 Feb 8;54(3):620-5. Аннотация

26. Visser LH, Van der Meché FG, Van Doorn PA, et al. Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study Group. Brain. 1995 Aug;118(Pt 4):841-7. Аннотация

27. Griffin JW, Li CY, Ho TW, et al. Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol. 1996 Jan;39(1):17-28. Аннотация

28. Langmuir AD, Bregman DJ, Kurland LT, et al. An epidemiologic and clinical evaluation of Guillain-Barré syndrome reported in association with the administration of swine influenza vaccines. Am J Epidemiol. 1984 Jun;119(6):841-79. Аннотация

29. Hemachudha T, Griffin DE, Chen WW, et al. Immunologic studies of rabies vaccination-induced Guillain-Barré syndrome. Neurology. 1988 Mar;38(3):375-8. Аннотация

30. Stowe J, Andrews N, Wise L, et al. Investigation of the temporal association of Guillain-Barré syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. Am J Epidemiol. 2009 Feb 1;169(3):382-8.Полный текст  Аннотация

31. Malkki H. CNS infections: Zika virus infection could trigger Guillain-Barré syndrome. Nat Rev Neurol. 2016 Apr;12(4):187.Полный текст  Аннотация

32. Anaya JM, Ramirez-Santana C, Salgado-Castaneda I, et al. Zika virus and neurologic autoimmunity: the putative role of gangliosides. BMC Med. 2016 Mar 21;14:49.Полный текст  Аннотация

33. Ralapanawa DM, Kularatne SA, Jayalath WA. Guillain-Barre syndrome following dengue fever and literature review. BMC Res Notes. 2015 Nov 27;8:729.Полный текст  Аннотация

34. Oehler E, Fournier E, Leparc-Goffart I, et al. Increase in cases of Guillain-Barré syndrome during a Chikungunya outbreak, French Polynesia, 2014 to 2015. Euro Surveill. 2015;20(48):30079. Аннотация

35. Mishra V, Harbada R, Sharma A. Fatal Guillain-Barre syndrome (GBS) in dengue. J Assoc Physicians India. 2015 Jun;63(6):94-6.Полный текст  Аннотация

36. Bandyopadhyay D, Ganesan V, Choudhury C, et al. Two uncommon causes of Guillain-Barré syndrome: hepatitis E and Japanese encephalitis. Case Rep Neurol Med. 2015;2015:759495.Полный текст  Аннотация

37. Simon O, Billot S, Guyon D, et al. Early Guillain-Barré syndrome associated with acute dengue fever. J Clin Virol. 2016 Apr;77:29-31. Аннотация

38. Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2017 Feb 27;(2):CD001798.Полный текст  Аннотация

39. Hughes RA, Hadden RD, Gregson NA, et al. Pathogenesis of Guillain-Barré syndrome. J Neuroimmunol. 1999 Dec;100(1-2):74-97. Аннотация

40. Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2014 Sep 19;(9):CD002063.Полный текст  Аннотация

41. Yuki N, Yoshino H, Sato S, et al. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology. 1990 Dec;40(12):1900-2. Аннотация

42. Ogawara K, Kuwabara S, Mori M, et al. Axonal Guillain-Barre syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol. 2000 Oct;48(4):624-31. Аннотация

43. Jacobs BC, Hazenberg MP, van Doorn PA, et al. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome. J Infect Dis. 1997 Mar;175(3):729-33. Аннотация

44. Walsh FS, Cronin M, Koblar S, et al. Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J Neuroimmunol. 1991 Oct;34(1):43-51. Аннотация

45. Gregson NA, Koblar S, Hughes RA. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Q J Med. 1993 Feb;86(2):111-7. Аннотация

46. Yuki N, Yoshino H, Sato S, et al. Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies. Muscle Nerve. 1992 Aug;15(8):899-903. Аннотация

47. Gregson NA, Jones D, Thomas PK, et al. Acute motor neuropathy with antibodies to GM1 ganglioside. J Neurol. 1991 Dec;238(8):447-51. Аннотация

48. Kuijf ML, Godschalk PC, Gilbert M, et al. Origin of ganglioside complex antibodies in Guillain-Barré syndrome. J Neuroimmunol. 2007 Aug;188(1-2):69-73. Аннотация

49. Ng JK, Malotka J, Kawakami N, et al. Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology. 2012 Dec 4;79(23):2241-8. Аннотация

50. Shu XM, Cai FC, Zhang XP. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy. Muscle Nerve. 2006 Feb;33(2):225-31. Аннотация

51. Yuki N, Susuki K, Koga M, et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc Natl Acad Sci USA. 2004 Aug 3;101(31):11404-9.Полный текст  Аннотация

52. Brown WF, Feasby TE. Conduction block and denervation in Guillain-Barré polyneuropathy. Brain. 1984 Mar;107(Pt 1):219-39. Аннотация

53. Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barre polyneuropathy. Brain. 1986 Dec;109(Pt 6):1115-26. Аннотация

54. Griffin JW, Li CY, Macko C, et al. Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J Neurocytol. 1996 Jan;25(1):33-51. Аннотация

55. Hafer-Macko C, Hsieh ST, Li CY, et al. Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol. 1996 Oct;40(4):635-44. Аннотация

56. Safranek TJ, Lawrence DN, Kurland LT, et al. Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two-state study. Expert Neurology Group. Am J Epidemiol. 1991 May 1;133(9):940-51. Аннотация

57. Ho TW, Hsieh ST, Nachamkin I, et al. Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology. 1997 Mar;48(3):717-24. Аннотация

58. Guillain-Barré Syndrome Study Group. Guillain-Barré syndrome: an Italian multicentre case-control study. Neurol Sci. 2000 Aug;21(4):229-34. Аннотация

59. McCarthy N, Giesecke J. Incidence of Guillain-Barré syndrome following infection with Campylobacter jejuni. Am J Epidemiol. 2001 Mar 15;153(6):610-4.Полный текст  Аннотация

60. Krauer F, Riesen M, Reveiz L, et al; WHO Zika Causality Working Group. Zika virus infection as a cause of congenital brain abnormalities and Guillain-Barré syndrome: systematic review. PLoS Med. 2017 Jan 3;14(1):e1002203.Полный текст  Аннотация

61. Cao-Lormeau VM, Blake A, Mons S, et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016 Apr 9;387(10027):1531-9.Полный текст  Аннотация

62. Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med. 2012 Jun 14;366(24):2294-304. Аннотация

63. World Health Organization. Assessment and management of Guillain-Barré syndrome in the context of Zika virus infection: interim guidance. Aug 2016 [internet publication].Полный текст

64. Public Health England. Guidance: Zika virus and Guillain-Barré syndrome. Aug 2017 [internet publication].Полный текст

65. Bazerbachi F, Haffar S, Garg SK, et al. Extra-hepatic manifestations associated with hepatitis E virus infection: a comprehensive review of the literature. Gastroenterol Rep (Oxf). 2016 Feb;4(1):1-15.Полный текст  Аннотация

66. Roscelli JD, Bass JW, Pang L. Guillain-Barré syndrome and influenza vaccination in the US Army, 1980-1988. 1991 May 1;133(9):952-5. Аннотация

67. Lehmann HC, Hartung HP, Kieseier BC, et al. Guillain-Barré syndrome after exposure to influenza virus. Lancet Infect Dis. 2010 Sep;10(9):643-51. Аннотация

68. Martín Arias LH, Sanz R, Sáinz M, et al. Guillain-Barré syndrome and influenza vaccines: a meta-analysis. Vaccine. 2015 Jul 17;33(31):3773-8. Аннотация

69. US Food and Drug Administration. FDA and CDC issue alert on Menactra meningococcal vaccine and Guillain Barre syndrome. Sep 2005 [internet publication].Полный текст

70. Kinnunen E, Junttila O, Haukka J, et al. Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barré syndrome. Am J Epidemiol. 1998 Jan 1;147(1):69-73.Полный текст  Аннотация

71. Maglione MA, Gidengil C, Das L, et al. Safety of vaccines used for routine immunization in the United States. Evidence Report/Technology Assessments, No. 215. Rockville, MD: Agency for Healthcare Research and Quality; 2014.Полный текст

72. Amundson DE, Goodman JC. Hodgkin's disease in association with Guillain-Barré-Strohl syndrome: case report. Mil Med. 1983 Jun;148(6):512-3. Аннотация

73. Anderson NE, Rosenblum MK, Graus F, et al. Autoantibodies in paraneoplastic syndrome associated with small cell lung cancer. Neurology. 1988 Sep;38(9):1391-8. Аннотация

74. Halls J, Bredkjaer C, Friis ML. Guillain-Barré syndrome: diagnostic criteria, epidemiology, clinical course and prognosis. Acta Neurol Scand. 1988 Aug;78(2):118-22. Аннотация

75. Klingon GH. The Guillain-Barré syndrome associated with cancer. Cancer. 1965 Feb;18:157-63. Аннотация

76. McLeod JG, Walsh JC. Peripheral neuropathy associated with lymphomas and other reticulosis. In: Dyck PJ, Thomas PK, Lambert EH, et al, eds. Peripheral neuropathy. 2nd ed, vol. 2. Philadelphia, PA: W.B. Saunders Co; 1984:2192-203.

77. Bertrand A, Kostine M, Barnetche T, et al. Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis. BMC Med. 2015 Sep 4;13:211.Полный текст  Аннотация

78. Mishra BB, Sommers W, Koski CL, et al. Acute inflammatory demyelinating polyneuropathy in the acquired immune deficiency syndrome (abstract). 110th annual meeting of the American Neurological Association. Chicago, IL, 1985. Ann Neurol. 1985 Jul;18(1):131-2.

79. Hagberg L, Malmvall BE, Svennerholm L, et al. Guillain-Barré syndrome as an early manifestation of HIV central nervous system infection. Scand J Infect Dis. 1986;18(6):591-2. Аннотация

80. Piette AM, Tusseau F, Vignon D, et al. Acute neuropathy coincident with seroconversion for anti-Lav/HTLV-III. Lancet. 1986 Apr 12;1(8485):852. Аннотация

81. Vendrell J, Heredia C, Pujol M, et al. Guillain-Barré syndrome associated with seroconversion of anti-HTLV-III. Neurology. 1987 Mar;37(3):544. Аннотация

82. Cornblath DR, McArthur JC, Kennedy PG, et al. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol. 1987 Jan;21(1):32-40. Аннотация

83. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology. A prospective study on the incidence and prognosis of Guillain-Barré syndrome in Emilia-Romagna region, Italy (1992-1993). Neurology. 1997 Jan;48(1):214-21. Аннотация

84. Asbury AK. New concepts of Guillain-Barré syndrome. J Child Neurol. 2000 Mar;15(3):183-91. Аннотация

85. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol. 1990;27 Suppl:S21-4. Аннотация

86. Van der Meché FG, Van Doorn PA, Meulstee J, et al. Diagnostic and classification criteria for the Guillain-Barré syndrome. Eur Neurol. 2001;45(3):133-9. Аннотация

87. Moulin DE, Hagen N, Feasby TE, et al. Pain in Guillain-Barré syndrome. Neurology. 1997 Feb;48(2):328-31. Аннотация

88. Wu X, Shen D, Li T, et al. Distinct clinical characteristics of pediatric Guillain-Barré syndrome: a comparative study between children and adults in northeast China. PLoS One. 2016 Mar 14;11(3):e0151611.Полный текст  Аннотация

89. Sakakibara R, Hattori T, Kuwabara S, et al. Micturitional disturbance in patients with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 1997 Nov;63(5):649-53.Полный текст  Аннотация

90. Zochodne DW. Autonomic involvement in Guillain-Barré syndrome: a review. Muscle Nerve. 1994 Oct;17(10):1145-55. Аннотация

91. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005 Nov 5;366(9497):1653-66. Аннотация

92. Albers JW, Kelly JJ Jr. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve. 1989 Jun;12(6):435-51. Аннотация

93. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol. 1993 Apr;33(4):333-42. Аннотация

94. Hiraga A, Mori M, Ogawara K, et al. Differences in patterns of progression in demyelinating and axonal Guillain-Barré syndromes. Neurology. 2003 Aug 26;61(4):471-4. Аннотация

95. Willison HJ, Veitch J, Paterson G, et al. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry. 1993 Feb;56(2):204-6.Полный текст  Аннотация

96. Overell JR, Hsieh ST, Odaka M, et al. Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004761.Полный текст  Аннотация

97. Odaka M, Yuki N, Yamada M, et al. Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome. Brain. 2003 Oct;126(Pt 10):2279-90.Полный текст  Аннотация

98. Yuki N, Sato S, Tsuji S, et al. An immunologic abnormality common to Bickerstaff's brain stem encephalitis and Fisher's syndrome. J Neurol Sci. 1993 Aug;118(1):83-7. Аннотация

99. Al-Din AN, Anderson M, Bickerstaff ER, et al. Brainstem encephalitis and the syndrome of Miller Fisher: a clinical study. Brain. 1982 Sep;105 (Pt 3):481-95. Аннотация

100. Mori M, Kuwabara S, Koga M, et al. IgG anti-GQ1b positive acute ataxia without ophthalmoplegia. J Neurol Neurosurg Psychiatry. 1999 Nov;67(5):668-70.Полный текст  Аннотация

101. Mori M, Kuwabara S, Fukutake T, et al. Clinical features and prognosis of Miller Fisher syndrome. Neurology. 2001 Apr 24;56(8):1104-6. Аннотация

102. Sekiguchi Y, Mori M, Misawa S, et al. How often and when Fisher syndrome is overlapped by Guillain-Barré syndrome or Bickerstaff brainstem encephalitis? Eur J Neurol. 2016 Jun;23(6):1058-63. Аннотация

103. Thompson HS. Adie's syndrome: some new observations. Trans Am Ophthalmol Soc. 1977;75:587-626.Полный текст  Аннотация

104. Caccavale A, Mignemi L. Acute onset of a bilateral areflexical mydriasis in Miller-Fisher syndrome: a rare neuro-ophthalmologic disease. J Neuroophthalmol. 2000;20:61-62. Аннотация

105. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain. 2002 Dec;125(Pt 12):2591-625.Полный текст  Аннотация

106. Van Sorge NM, van der Pol WL, Jansen MD, et al. Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome. Autoimmun Rev. 2004 Feb;3(2):61-8. Аннотация

107. Hadden RD, Cornblath DR, Hughes RA, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Ann Neurol. 1998 Nov;44(5):780-8. Аннотация

108. Van den Bergh PY, Piéret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 2004 Apr;29(4):565-74. Аннотация

109. Brown WF, Feasby TE, Hahn AF. Electrophysiological changes in the acute "axonal" form of Guillain-Barré syndrome. Muscle Nerve. 1993 Feb;16(2):200-5. Аннотация

110. Murray NM, Wade DT. The sural sensory action potential in Guillain-Barré syndrome. Muscle Nerve. 1980 Sep-Oct;3(5):444. Аннотация

111. Paradiso G, Tripoli J, Galicchio S, et al. Epidemiological, clinical, and electrodiagnostic findings in childhood Guillain-Barré syndrome: a reappraisal. Ann Neurol. 1999 Nov;46(5):701-7. Аннотация

112. DiCapua DB, Lakraj AA, Nowak RJ, et al. Relationship between cerebrospinal fluid protein levels and electrophysiologic abnormalities in Guillain-Barré syndrome. J Clin Neuromuscul Dis. 2015 Dec;17(2):47-51. Аннотация

113. Lavi R, Yarnitsky D, Rowe JM, et al. Standard vs atraumatic Whitacre needle for diagnostic lumbar puncture: a randomized trial. Neurology. 2006 Oct 24;67(8):1492-4. Аннотация

114. Arendt K, Demaerschalk BM, Wingerchuk DM, Camann W. Atraumatic lumbar puncture needles: after all these years, are we still missing the point? Neurologist. 2009 Jan;15(1):17-20. Аннотация

115. Nath S, Koziarz A, Badhiwala JH, et al. Atraumatic versus conventional lumbar puncture needles: a systematic review and meta-analysis. Lancet. 2018 Mar 24;391(10126):1197-204. Аннотация

116. Rochwerg B, Almenawer SA, Siemieniuk RAC, et al. Atraumatic (pencil-point) versus conventional needles for lumbar puncture: a clinical practice guideline. BMJ. 2018 May 22;361:k1920.Полный текст  Аннотация

117. Ahmed SV, Jayawarna C, Jude E. Post lumbar puncture headache: diagnosis and management. Postgrad Med J. 2006 Nov;82(973):713-6.Полный текст  Аннотация

118. Arevalo-Rodriguez I, Ciapponi A, Roqué i Figuls M, et al. Posture and fluids for preventing post-dural puncture headache. Cochrane Database Syst Rev. 2016 Mar 7;(3):CD009199.Полный текст  Аннотация

119. Lawn ND, Fletcher DD, Henderson RD, et al. Anticipating mechanical ventilation in Guillain-Barré syndrome. Arch Neurol. 2001;58:893-898.Полный текст  Аннотация

120. Sundar U, Abraham E, Gharat A, et al. Neuromuscular respiratory failure in Guillain-Barré syndrome: evaluation of clinical and electrodiagnostic predictors. J Assoc Physicians India. 2005 Sep;53:764-8. Аннотация

121. Sharshar T, Chevret S, Bourdain F, et al. Early predictors of mechanical ventilation in Guillain-Barré syndrome. Crit Care Med. 2003 Jan;31(1):278-83. Аннотация

122. Hiraga A, Kuwabara S. Early prediction of prognosis in Guillain-Barré syndrome. Lancet Neurol. 2007 Jul;6(7):572-3. Аннотация

123. O'Leary CP, Veitch J, Durward WF, et al. Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. J Neurol Neurosurg Psychiatry. 1996 Dec;61(6):649-51.Полный текст  Аннотация

124. Chiba A, Kusunoki S, Obata H, et al. Ganglioside composition of the human cranial nerves, with special reference to pathophysiology of Miller Fisher syndrome. Brain Res. 1997 Jan 16;745(1-2):32-6. Аннотация

125. Durand MC, Porcher R, Orlikowski D, et al. Clinical and electrophysiological predictors of respiratory failure in Guillain-Barré syndrome: a prospective study. Lancet Neurol. 2006 Dec;5(12):1021-8. Аннотация

126. Ropper AH, Wijdicks E, Truax B. Guillain-Barré syndrome. Philadelphia, PA: F.A. Davies; 1991:92.

127. Barber HS. Polyradiculoneuritis (Guillain-Barré's syndrome) in East Anglia. Lancet. 1940 Nov 2;236(6114):548-50.

128. Pillay N, Oliver S. Evoked potentials in Fisher's syndrome (abstract). XIX Canadian Congress of Neurological Sciences: abstracts of the Scientific Program. Edmonton, Alberta, 1984. Can J Neurol Sci. 1984 May;11(2):341.

129. Willison HJ, Veitch J, Paterson G, et al. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry. 1993 Feb;56(2):204-6.Полный текст  Аннотация

130. Yuki N, Sato S, Tsuji S, et al. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology. 1993 Feb;43(2):414-7. Аннотация

131. Rajabally YA, Durand MC, Mitchell J, et al. Electrophysiological diagnosis of Guillain-Barré syndrome subtype: could a single study suffice? J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):115-9. Аннотация

132. Fross RD, Daube JR. Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings. Neurology. 1987 Sep;37(9):1493-8. Аннотация

133. Ropper AH, Wijdicks E, Truax B. Guillain-Barré syndrome. Philadelphia, PA: F.A. Davies; 1991:155-60.

134. Andersson T, Siden A. A clinical study of the Guillain-Barré syndrome. Acta Neurol Scand. 1982 Sep;66(3):316-27. Аннотация

135. Ropper AH, Wijdicks E, Truax B. Guillain-Barré syndrome. Philadelphia, PA: F.A. Davies; 1991:94-5.

136. Ropper AH, Marmarou A. Mechanism of pseudotumor in Guillain-Barré syndrome. Arch Neurol. 1984 Mar;41(3):259-61. Аннотация

137. Soar J, Nolan JP, Böttiger BW, et al; Adult advanced life support section collaborators. European Resuscitation Council Guidelines for resuscitation 2015: section 3. Adult advanced life support. Resuscitation. 2015 Oct;95:100-47. Аннотация

138. Colquhoun MC, Handley AJ, Evans TR, eds. ABC of resuscitation. 5th ed. Wiley-Blackwell; 2004.

139. Soar J, Nolan JP, Böttiger BW, et al. European Resuscitation Council guidelines for resuscitation 2015: Section 3. Adult advanced life support. Resuscitation. 2015;95:100-147. Аннотация

140. Kornberg AJ, Pestronk A, Blume GM, et al. Selective staining of the cerebellar molecular layer by serum IgG in Miller-Fisher and related syndromes. Neurology. 1996 Nov;47(5):1317-20. Аннотация

141. Koga M, Yuki N, Hirata K. Antiganglioside antibody in patients with Guillain-Barré syndrome who show bulbar palsy as an initial symptom. J Neurol Neurosurg Psychiatry. 1999 Apr;66(4):513-6.Полный текст  Аннотация

142. Gorson KC, Ropper AH, Muriello MA, et al. Prospective evaluation of MRI lumbosacral nerve root enhancement in acute Guillain-Barré syndrome. Neurology. 1996 Sep;47(3):813-7. Аннотация

143. Hughes RA, Newsom-Davis JM, Perkin GD, et al. Controlled trial of prednisolone in acute polyneuropathy. Lancet. 1978;2:750-753. Аннотация

144. Hughes RA, Wijdicks EF, Benson E, et al; Multidisciplinary Consensus Group. Supportive care for patients with Guillain-Barré syndrome. Arch Neurol. 2005 Aug;62(8):1194-8.Полный текст  Аннотация

145. Soar J, Nolan JP, Böttiger BW, et al. European Resuscitation Council guidelines for resuscitation 2015. Section 3: adult advanced life support. Resuscitation. 2015;95:100-147. Аннотация

146. Resuscitation Council UK. Resuscitation guidelines. Chapter 7: adult advanced life support. 2015. https://www.resus.org.uk (last accessed 27 October 2017).Полный текст

147. Truax B. Autonomic disturbances in Guillain-Barré syndrome. Semin Neurol. 1984;4(4):462-8.

148. Lawn ND, Wijdicks EF. Fatal Guillain-Barré syndrome. Neurology. 1999 Feb;52(3):635-8. Аннотация

149. Liu J, Wang LN, McNicol ED. Pharmacological treatment for pain in Guillain-Barré syndrome. Cochrane Database Syst Rev. 2015 Apr 9;(4):CD009950.Полный текст  Аннотация

150. Burns TM, Lawn ND, Low PA, et al. Adynamic ileus in severe Guillain-Barré syndrome. Muscle Nerve. 2001 Jul;24(7):963-5. Аннотация

151. Hughes RA, Swan AV, Raphael JC, et al. Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain. 2007 Sep;130(Pt 9):2245-57. Аннотация

152. Hughes RA, Wijdicks EF, Barohn R, et al. Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2003 Sep 23;61(6):736-40.Полный текст  Аннотация

153. Donofrio PD, Berger A, Brannagan TH 3rd, et al. Consensus statement: the use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the AANEM ad hoc committee. Muscle Nerve. 2009 Nov;40(5):890-900. Аннотация

154. Elovaara I, Apostolski S, van Doorn P, et al; EFNS. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases. Eur J Neurol. 2008 Sep;15(9):893-908.Полный текст  Аннотация

155. Hughes RA, Brassington R, Gunn AA, et al. Corticosteroids for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2016 Oct 24;(10):CD001446.Полный текст  Аннотация

156. McKhann GM, Griffin JW, Cornblath DR, et al. Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol. 1988 Apr;23(4):347-53. Аннотация

157. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome. Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. Ann Neurol. 1987 Dec;22(6):753-61. Аннотация

158. Osterman PO, Fagius J, Lundemo G, et al. Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet. 1984 Dec 8;2(8415):1296-9. Аннотация

159. Dalakas MC. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile. Pharmacol Ther. 2004 Jun;102(3):177-93. Аннотация

160. Yu Z, Lennon VA. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med. 1999 Jan 21;340(3):227-8. Аннотация

161. Khan F, Amatya B. Rehabilitation interventions in patients with acute demyelinating inflammatory polyneuropathy: a systematic review. Eur J Phys Rehabil Med. 2012 Sep;48(3):507-22.Полный текст  Аннотация

162. Raphael JC, Masson C, Morice V, et al. The Landry-Guillain-Barré syndrome. Study of prognostic factors in 223 cases [in French]. Rev Neurol (Paris). 1986;142(6-7):613-24. Аннотация

163. Raphael JC, Chevret S, Harboun M, et al. Intravenous immune globulins in patients with Guillain-Barré syndrome and contraindications to plasma exchange: 3 days versus 6 days. J Neurol Neurosurg Psychiatry. 2001 Aug;71(2):235-8.Полный текст  Аннотация

164. Pritchard J, Hughes RA, Hadden RD, et al. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2016 Nov 15;(11):CD008630.Полный текст  Аннотация

165. Fletcher DD, Lawn ND, Wolter TD, et al. Long-term outcome in patients with GBS requiring mechanical ventilation. Neurology. 2000 Jun 27;54(12):2311-5. Аннотация

166. Chiò A, Cocito D, Leone M, et al; Piemonte and Valle d'Aosta Register for Guillain-Barré Syndrome. Guillain-Barré Syndrome: a prospective, population-based incidence and outcome survey. Neurology. 2003 Apr 8;60(7):1146-50. Аннотация

167. Stewart GJ, Pollard JD, McLeod JG, et al. Calcium homeostasis in immobilization: an example of resorptive hypercalcinuria. N Engl J Med. 1982 May 13;306(19):1136-40. Аннотация

168. Meythaler JM, Korkor AB, Nanda T, et al. Immobilization hypercalcemia associated with Landry-Guillain-Barré syndrome. Successful therapy with combined calcitonin and etidronate. Arch Intern Med. 1986 Aug;146(8):1567-71. Аннотация

169. Emmanuel AV, Shand AG, Kamm MA. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. Aliment Pharmacol Ther. 2004 Mar 15;19(6):687-94. Аннотация

170. Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med. 1999 Jul 15;341(3):137-41.Полный текст  Аннотация

171. Gracey DR, McMichan JC, Divertie MB, et al. Respiratory failure in Guillain-Barré syndrome. a 6-year experience. Mayo Clin Proc. 1982 Dec;57(12):742-6. Аннотация